Stay updated on Ponatinib for Medullary Thyroid Cancer Clinical Trial
Sign up to get notified when there's something new on the Ponatinib for Medullary Thyroid Cancer Clinical Trial page.

Latest updates to the Ponatinib for Medullary Thyroid Cancer Clinical Trial page
- Check7 days agoChange DetectedThe study status is Withdrawn/Closed by sponsor with enrollment at 0, indicating no active recruitment.SummaryDifference0.5%

- Check14 days agoNo Change Detected
- Check36 days agoChange Detected- Updated page to v3.2.0 and removed the Medullary thyroid carcinoma resource. - Added a government funding/operating-status notice directing users to NIH and OPM sites for current operations.SummaryDifference5%

- Check43 days agoChange DetectedCore content terminology updated from “Medullary thyroid gland carcinoma” to “Medullary thyroid carcinoma” and the release version updated to v3.1.0.SummaryDifference0.1%

- Check58 days agoChange DetectedVersion updated from v3.0.1 to v3.0.2 and the 'Back to Top' link was removed; no core content or pricing/availability changes detected.SummaryDifference0.2%

- Check65 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.SummaryDifference0.2%

- Check72 days agoChange DetectedThe web page has been updated to include a new facility name and location, as well as specific medical terms related to medullary thyroid gland carcinoma and associated treatments. Additionally, the version has been revised from v2.16.12 to v3.0.0.SummaryDifference5%

Stay in the know with updates to Ponatinib for Medullary Thyroid Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ponatinib for Medullary Thyroid Cancer Clinical Trial page.